Papel de la neoadyuvancia: Reestadificación sistémica y locorregional postneoadyuvancia

Autores/as

  • P. J. Paredes Cotoré Complejo Hospitalario Universitario de Santiago. Área Sanitaria de Santiago de Compostela e Barbanza.
  • J. E. Casal Núñez Complejo Hospitalario Universitario de Vigo. Área Sanitaria de Vigo.

Palabras clave:

cáncer de recto

Resumen

Artículo especial: capítulo 2 de la “Guía práctica para el tratamiento quirúrgico del cáncer de recto" del Grupo Gallego de Coloproctología y la Sociedad de Cirugía de Galicia

Descargas

Los datos de descargas todavía no están disponibles.

Citas

51. Ngan S. Y., Burmeister B., Fisher R. J., Solomon M., Goldstein D., Joseph D., et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012; 30:3827-33. Doi: 10.1200/JCO.2012.42.9597. Erratum in: J Clin Oncol. 2013 20; 31:399.

52. Roh M. S., Colangelo L. H., O’Connell M. J., Yothers G., Deutsch M., Allegra C. J., et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009; 27:5124-30. Doi: 10.1200/JCO.2009.22.0467.

53. Glimelius B., Tiret E., Cervantes A., Arnold D.; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnose, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6:vi81-8. Doi: 10.1093/annonc/mdt240..

54. Dou R., Hei S., Deng E., Wang J. Comparison of guidelines on rectal cancer: exception proves the rule? Gastroenterol Rep (Oxf). 2021; 9:290-298. Doi: 10.1093/gastro/goab034.

55. Jin J., Tang E., Hu C., Jiang L. M., Jiang J., Li N., et al. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR). J Clin Oncol. 2022; 40:1681-92. Doi: 10.1200/JCO.21.01667.

56. van der Valk M. J. M., Marijnen C. A. M., van Etten B., Dijkstra E. A., Hilling D. E., Kranenbarg E. M., et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial. Radiother Oncol. 2020; 147:75-83. Doi: 10.1016/j.radonc.2020.03.011. Erratum in: Radiother Oncol. 2020 Jun; 147:e1.

57. Conroy T., Lamfichekh N., Etienne P. L., et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. J Clin Oncol. 2020; 38S: ASCO #4007.

58. García Aguilar J., Patil S., Gollub M. J., Kim J. K., Yuval J. B., Thompson H. M., et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022; 40:2546-56. Doi: 10.1200/JCO.22.00032.

59. Bisschop C., Tjalma J. J., Hospers G. A., Van Geldere D., de Groot J. W., Wiegman E. M., et al. Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer. Ann Surg Oncol. 2015; 22:552-6. Doi: 10.1245/s10434-014-3996-8.

60. Ayez N., Alberda W. J., Burger J. W., Eggermont A. M., Nuyttens J. J., Dwarkasing R. S., et al. Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced 57 rectal cancer necessary? Ann Surg Oncol. 2013; 20:155-60. Doi: 10.1245/s10434-012-2537-6.

61. Davids J. S., Alavi K., Andres Cervera-Servin J., Choi C. S., Sturrock P. R., Sweeney W. B., Maykel J. A. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study. Int J Surg. 2014; 12:1295-9. Doi: 10.1016/j.ijsu.2014.10.033..

62. Liu G. C., Zhang X., Xie E., An X., Cai P. Q., Zhu E., et al. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Medicine (Baltimore). 2015; 94:e2074. Doi: 10.1097/MD.0000000000002074.

63. Jaffe T. A., Neville A. M., Bashir M. R., Uronis HEI, Thacker J. M. Is follow-up CT imaging of the chest and abdome necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnose? Colorectal Dis. 2013; 15:e654-8. Doi: 10.1111/codi.12372..

64. Schneider D. A., Akhurst T. J., Ngan S. Y., Warrier S. K., Michael M., Lynch A. C., Te Marvelde L., Heriot A. G. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer. Dis Colon Rectum. 2016; 59:179-86. Doi: 10.1097/DCR.0000000000000557.

65. Maffione A. M., Marzola M. C., Capirci C., Colletti P. M., Rubello D. Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2015; 204:1261-8. Doi: 10.2214/AJR.14.13210.

66. Cote A., Florin F. G., Mois E., Elisei R., Badea R., Mare C., et al. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy. Ann Ital Chir. 2018; 89:168-176.

67. Memon S., Lynch A. C., Bressel M., Wise A. G., Heriot A. G. Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. Colorectal Dis. 2015; 17:748-61. Doi: 10.1111/codi.12976.

68. Barbaro B., Fioruci C., Tebala C., Valentini V., Gambacorta M. A., Vecchio F. M., et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology. 2009; 250:730-9. Doi: 10.1148/radiol.2503080310.

69. Maas M., Lambregts D. M., Nelemans P. J., Heijnen A., Martens M. H., Leijtens J. W., et al., Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Dixital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol. 2015; 22:3873-80. Doi: 10.1245/s10434-015-4687-9.

70. Yang L., Xia C., Liu D., Fang X., Pan X., Ma L., Wu B. The role of readout-segmented boto-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Acta Radiol. 2020 Sep; 61:1155-64. Doi: 10.1177/0284185119897354.

71. Maas M., Dijkhoff RAP, Beets-Tan R. Rectal Cancer: Assessing Response to Neoadjuvant Therapy. Magn Reson Imaging. Clin N Am. 2020; 28:117-26. Doi: 10.1016/j.mric.2019.09.004.

72. Munk N. E., Bondeven P., Pedersen B. G. Diagnostic performance of MRI and endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy: a systematic review of the literature. Acta Radiol. 2021; 20:2841851211065925. Doi: 10.1177/0284185 1211065925..

73. Xu Q., Xu E., Sun H., Jiang T., Xie S., Ooi B. Y., Ding E. MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends. Cancer Manag Res. 2021 13:4317-28. Doi: 10.2147/CMAR.S309252.

Descargas

Publicado

26-02-2026

Cómo citar

Paredes Cotoré, P. J., & Casal Núñez, J. E. (2026). Papel de la neoadyuvancia: Reestadificación sistémica y locorregional postneoadyuvancia. Revista De Cirugía De Galicia, 10(14). Recuperado a partir de https://revista.proeditio.com/RevistaSociga/article/view/8918

Número

Vol. 10 Núm. 14 (2026): Revista de Cirugía de Galicia (enero-junio) (Suplemento 1)

Sección

Artículos especiales

Licencia

Derechos de autor 2026 P. J. Paredes Cotoré1, J. E. Casal Núñez2

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.